Cellular Biomedicine Group (CBMG) Reports Q2 Loss of $0.52/Share

Cellular Biomedicine Group (NASDAQ: CBMG) reported Q2 EPS of ($0.52), versus ($0.44) reported last year. Revenue for the quarter came in at $71.6 thousand, versus $656.96 thousand reported last year.

For earnings history and earnings-related data on Cellular Biomedicine Group (CBMG) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• AXIL Brands (AXIL) Tops Q4 EPS by 4c
• Toll Brothers (TOL) Tops Q3 EPS by 5c, reaffirms guidance